# Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.

> **NCT07379255** · — · RECRUITING · sponsor: **Qilu Hospital of Shandong University** · enrollment: 266 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **OTHER:** Organoid culture

## Key facts

- **NCT ID:** NCT07379255
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 266 (ESTIMATED)
- **Last updated:** 2026-01-30

## Collaborators

- The Second Hospital of Shandong University
- Qianfoshan Hospital
- Shandong Provincial Hospital
- Shandong Province Third hospital
- Taian City Central Hospital
- Weifang People's Hospital
- Binzhou Medical University
- The Affiliated Hospital of Qingdao University
- Jining First People's Hospital
- Liaocheng People's Hospital
- Linyi People's Hospital
- Yantai Yuhuangding Hospital
- Zibo Central Hospital
- Dezhou Hospital Qilu Hospital of Shandong University
- Zaozhuang Municipal Hospital
- Qilu Hospital of Shandong University (Qingdao)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07379255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07379255, "Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07379255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*